BCM
BIOS Capital Management Portfolio holdings
AUM
$72.6M
This Quarter Return
+5.74%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$94.1M
AUM Growth
–
Cap. Flow
+$94.1M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
6
New
6
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
ACTU
Actuate Therapeutics, Inc. Common stock
ACTU
|
$78.8M |
| 2 |
Cognition Therapeutics
CGTX
|
$4.21M |
| 3 |
RNTX
Rein Therapeutics, Inc. Common Stock
RNTX
|
$3.89M |
| 4 |
Lantern Pharma
LTRN
|
$3.85M |
| 5 |
IN8bio
INAB
|
$2.21M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ACTU
1
Actuate Therapeutics, Inc. Common stock
ACTU
$186M
| $78.8M | 83.69% |
+9,893,651
| New | +$78.8M |
|
|
2
Cognition Therapeutics
CGTX
$179M
| $4.21M | 4.47% |
+6,000,000
| New | +$4.21M |
|
|
RNTX
3
Rein Therapeutics, Inc. Common Stock
RNTX
$30.9M
| $3.89M | 4.13% |
+1,690,751
| New | +$3.89M |
|
|
4
Lantern Pharma
LTRN
$43.3M
| $3.85M | 4.09% |
+1,207,709
| New | +$3.85M |
|
|
5
IN8bio
INAB
$9.94M
| $2.21M | 2.35% |
+8,600,001
| New | +$2.21M |
|
|
IRD
6
Opus Genetics, Inc. Common Stock
IRD
$76.7M
| $1.18M | 1.26% |
+995,249
| New | +$1.18M |
|